First confirmed case of vancomycin-resistant Enterococcus faecium meningitis in Turkey: Case report and literature review

Journal of Chemotherapy

Volumn 16, Issue 6, 2004, Pages 608-611

  Inan, Dilara ^a   Gunseren, F ^a   Colak, D ^a   Saba, R ^a   Kazan, S ^a   Mamikoglu, L ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Enterococcus faecium; Meningitis; Vancomycin resistant

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; METICILLIN; OXAZOLIDINONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; AMNESIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BLOOD CULTURE; BRAIN ABSCESS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENTEROCOCCUS FAECIUM; ENURESIS; HEADACHE; HISTOPATHOLOGY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; MALE; REVIEW; TURKEY (REPUBLIC); VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 12544253573     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.6.608     Document Type: Review

References (30)

1. Moellering RC. Enterococcus species, Streptococcus bonis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edn. New York: Churchill Livingstone, 2000: 2147-2156.
2. Edmond MB. Multidrug-resistant enterococci and the threat of vancomycin-resistant Staphylococcus aureus. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 3rd edn. Baltimore: Williams and Wilkins, 1997: 339-355.
3. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
4. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
5. Stevenson KB, Murray EW, Sarubbi FA. Enterocoocal meningitis: report of four cases and review. Clin Infect Dis 1994;18:233-239.
6. Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB. Group D enterococcal meningitis: clinical and therapeutic considerations with report of three cases and review of the literature. Arch Intern Med 1976;136:883-886.
7. Ready LB, Heifer D. Bacterial meningitis in parturients after epidural anesthesia. Anesthesiology 1989;71:988-990.
8. Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001;33:477-482.
9. Fazal BA, Turett GS, Chilimuri SS, Mendoza CM, Telzak EE. Community acquired enterococcal meningitis in an adult. Clin Infect Dis 1995;20:725-726.
10. Losonsky GA, Wolf A, Schwalbe RS, Nataro J, Gibson CB, Lewis EW. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis 1994;19:163-165.
11. Tush GM, Huneycutt S, Phillips A, Ward JD. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin Infect Dis 1998;26:1460-1461.
12. Perez Mato S, Robinson S, Begue RE. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr Infect Dis J 1999;18:483-484.
13. Tomieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-772.
14. Eliopoulos GM, Wennersten CB, Gold HS, et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother 1998;42:1088-1092.
15. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20:1137-1144.
16. Ricaurte JC, Boucher HW, Turett GS, Moellering RC, Labombardi VJ, Kislak JW. Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. Clin Microbiol Infect 2001;7:17-21.
17. Nachman SA, Verma R, Egnor M. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure. Microb Drug Resist 1995;1:95-96.
18. Sarma PS, Mohanty S. Mixed meningitis: association of Acinetobacter calcoaceticus var. Iwoffi and Streptococcus faecium. Postgrad Med J 1995;71:295-296.
19. Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998;22:207-209.
20. Cocito C, Di Giambattista M, Nyssen E, Vannuffel P. Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother 1997;39 (suppl A):7-13.
21. Nachman SA, Phillips A, Gray SL, Talbot GH. Treatment of vancomycin-resistant Enterococcus faecium central nervous system infection with intrathecal administration of quinupristin-dalfopristin [abstract]. In: Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Washington, DC: American Society for Microbiology, 1998: 217.
22. Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Treatment of vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. J Infect 2000;41:95-97.
23. Garey KW, Tesoro E, Muggia V, Pasquier O, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin/dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis. Pharmacotherapy 2001;21:748-750.
24. Williamson JC, Glazier SS, Peacock JE. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg 2002;104:54-56.
25. Gransden WR, King A, Marossy D. Quinupristin/dalfopristin in neonatal Enterococcus faecium meningitis. Arch Dis Child Fetal Neonatal Ed 1998;78:F235-236.
26. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med 2001;29:2383-2385.
27. Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and review of the literature. Scand J Infect Dis 2001;33:375-379.
28. Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 2001;20:432-434.
29. Graham PL, Ampofo K, Saiman L. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 2002;21:798-800.
30. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721.